Brief: Black Diamond Therapeutics Reports Q4 And FY 2021 Financial Results
17/03/2022 21:09
March 17 (Reuters) - Black Diamond Therapeutics Inc
BDTX.O :
* BLACK DIAMOND THERAPEUTICS REPORTS FOURTH QUARTER AND FULL
YEAR
2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* BLACK DIAMOND THERAPEUTICS - ENDED 2021 WITH ABOUT $209.8
MILLION CASH, CASH EQUIVALENTS, SUFFICIENT TO FUND OPERATING
EXPENSES, CAPEX REQUIREMENTS INTO 2024
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.71
* Q4 EARNINGS PER SHARE VIEW $-1.01 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4sMTQj
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com;))